Department of Biomedical, Surgical and Dental Sciences, University "La Statale", Milan, Italy -
IRCCS Istituto Ortopedico Galeazzi, Milan, Italy -
Eur J Phys Rehabil Med. 2022 Dec;58(0):888-891. doi: 10.23736/S1973-9087.22.07767-X. Epub 2022 Nov 3.
This special paper reflects on trustworthiness and its implications for scientific medical journals and all the communities they serve: health professionals, policymakers, the public, and a specific discipline, in our case, Physical and Rehabilitation Medicine. We start from a recent episode: a paper claimed the untrustworthiness of two randomised controlled trials (RCTs) published in the European Journal of Physical and Rehabilitation Medicine based on a newly developed trustworthiness scale, used until now only in systematic reviews. This likely represents the first case of applying such a scale focusing on a single leading author. Developing a proper answer to this case led us to present some insights from the perspective of a Journal editor. We discuss the impact of false research results, why trust is needed in science and medicine, the difference between untrust and false results, the problems in judging trustworthiness, the unfortunately weak capacity of the peer review system in preventing these issues, the problems of "post-hoc" judgements and the emerging ethical issues. We conclude with some suggestions for the future based on prevention at the system level.
医疗专业人员、政策制定者、公众以及我们案例中的特定学科——物理医学与康复。我们从最近的一个事件开始:一篇论文声称,根据一个新开发的可信度量表,发表在《欧洲物理医学与康复医学杂志》上的两项随机对照试验(RCT)不可信,该量表以前仅用于系统评价。这可能是首次针对单个主要作者应用此类量表的情况。为了对这一案例做出恰当的回应,我们从期刊编辑的角度提出了一些见解。我们讨论了虚假研究结果的影响、科学和医学为何需要信任、不可信与虚假结果的区别、判断可信度的问题、同行评审系统在防止这些问题方面的不幸弱点、事后判断的问题以及新兴的伦理问题。最后,我们根据系统层面的预防提出了一些未来的建议。